Elanco Animal Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance above estimates. Also, the company issued Q3 sales guidance above estimates.

Elanco Director Purchases 40,000 Shares for $936,000

Lawrence Erik Kurzius, Director at Elanco Animal Health, purchased 40,000 shares at $23.40 per share on August 20, 2026, expanding his direct holdings by 27%. The insider purchase signals confidence in the company, with analysts showing strong bullish sentiment—89% of 18 analysts rate it a buy with a median 12-month price target of $32, representing potential 31% upside.

Elanco Animal Health Announces On-Time Completion Of 25K-Square-Foot Manufacturing Expansion Of Its Elwood, Kansas Manufacturing Site

The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipelineINDIANAPOLIS, Aug. 26, 2026 /PRNewswire/ -- Elanco Animal

Netflix, Eli Lilly, Elanco Animal Health And More Stock On CNBC’s ‘Final Trades’

Bryn Talkington picked Horizon Kinetics, Stephanie Link chose Elanco Animal Health, and Jason Snipe recommended Netflix.

CNBC Halftime Report Final Trades: Netflix, Eli Lilly, Elanco Animal Health, Horizon Kinetics Inflation Beneficiaries ETF